US Edition
News from healtheconomics.com
Information about healtheconomics.com
Where is healtheconomics.com located?healtheconomics.com's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top healtheconomics.com News
FDA · United StatesOn Thursday, the U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb & Co.’s (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL). Breyanzi is administered as a one-time infusion. Breyanzi is now the only CAR T cell therapy approved by the FDA for five cancer types, the most of a…See the Story
What's Going On With Bristol-Myers Squibb Stock Friday? - Bristol-Myers Squibb (NYSE:BMY)
75% Center coverage: 4 sources
